A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro

Doxorubicin (DOX) is one of the most commonly used chemotherapeutic treatments for a wide range of cancers. N-benzyladriamycin-14-valerate (AD198) is a lipophilic anthracycline that has been shown to target conventional and novel isoforms of protein kinase C (PKC) in cytoplasm of cells. Because of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Rathore, Kusum, Cekanova, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590339/
https://www.ncbi.nlm.nih.gov/pubmed/26451087
http://dx.doi.org/10.2147/DDDT.S90859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590339/
https://www.ncbi.nlm.nih.gov/pubmed/26451087
http://dx.doi.org/10.2147/DDDT.S90859

Ejemplares similares